Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.

Item
http://www.wikidata.org/entity/Q46646002
Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experienceAllogeneic islet transplantation.Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeStable renal function after islet transplantation: importance of patient selection and aggressive clinical management.Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.State of the art of clinical islet transplantation and novel protocols of immunosuppression.Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes.Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR).Sirolimus interacts with pathways essential for podocyte integrity.Resolution of severe atopic dermatitis after tacrolimus withdrawal.
P2860

Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing.

Item
http://www.wikidata.org/entity/Q46646002
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Proteinuria developing after c ...... d increased tacrolimus dosing.
@en
Proteinuria developing after c ...... d increased tacrolimus dosing.
@nl
type
label
Proteinuria developing after c ...... d increased tacrolimus dosing.
@en
Proteinuria developing after c ...... d increased tacrolimus dosing.
@nl
prefLabel
Proteinuria developing after c ...... d increased tacrolimus dosing.
@en
Proteinuria developing after c ...... d increased tacrolimus dosing.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Proteinuria developing after c ...... d increased tacrolimus dosing.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-6143.2005.01013.X
P407
P433
P478
P50
P577
P5875
P698